Scentech Medical’s laboratory, located in the Weizmann Science Park, Ness Ziona, Israel,
is uniquely suited for mapping biomarkers in exhaled breath thanks to its state-of-the-art equipment and a team of highly skilled researchers. The high-resolution GCMS with thermal desorption unit allows our team to perform analysis on and accurately identify a plethora of volatile and semi-volatile organic compounds.
Scentech Medical has joined forces with the medical staff at the Meir Medical Center in Kfar Saba to conduct a trial aiming to map the Coronavirus fingerprint. For this trial, breath samples of patients with various stages of the disease are being collected and analyzed to identify the unique characteristics of the compounds emitted by Coronavirus patients.